Tarsus Drug Patent Portfolio

Tarsus owns 1 orange book drug protected by 6 US patents Given below is the list of Tarsus's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US10835517 Methods for treating ocular demodex using isoxazoline parasiticide formulations 14 Dec, 2038
Active
US11197847 Isoxazoline parasiticide formulations and methods for treating blepharitis 14 Dec, 2038
Active
US11690826 Methods for treating demodex blepharitis using lotilaner formulations 14 Dec, 2038
Active
US11690827 Methods for treating ocular Demodex using lotilaner formulations 14 Dec, 2038
Active
US11752137 Ophthalmic compositions for treating ocular Demodex using lotilaner formulations 14 Dec, 2038
Active
US8383659 Isoxazoline derivatives as pesticides 17 Jan, 2030
Active


Given below is the list of recent legal activities going on the following drug patents of Tarsus.

Activity Date Patent Number
Patent litigations
Payment of Maintenance Fee, 4th Yr, Small Entity 14 May, 2024 US10835517
Recordation of Patent Grant Mailed 12 Sep, 2023 US11752137
Recordation of Patent eGrant 12 Sep, 2023 US11752137
Patent eGrant Notification 12 Sep, 2023 US11752137
Email Notification 12 Sep, 2023 US11752137
Mail Patent eGrant Notification 12 Sep, 2023 US11752137
Patent Issue Date Used in PTA Calculation 12 Sep, 2023 US11752137
Email Notification 24 Aug, 2023 US11752137
Issue Notification Mailed 23 Aug, 2023 US11752137
Application Is Considered Ready for Issue 27 Jul, 2023 US11752137
Dispatch to FDC 27 Jul, 2023 US11752137
Response to Reasons for Allowance 19 Jul, 2023 US11752137
Issue Fee Payment Verified 19 Jul, 2023 US11752137
Issue Fee Payment Received 19 Jul, 2023 US11752137
Email Notification 06 Jul, 2023 US11690826


Tarsus's Family Patents


Family Patents



Tarsus Drug List

Given below is the complete list of Tarsus's drugs and the patents protecting them.


1. Xdemvy

Xdemvy is protected by 6 patents, out of which none have expired yet. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US10835517 Methods for treating ocular demodex using isoxazoline parasiticide formulations 14 Dec, 2038
(14 years from now)
Active
US11197847 Isoxazoline parasiticide formulations and methods for treating blepharitis 14 Dec, 2038
(14 years from now)
Active
US11690826 Methods for treating demodex blepharitis using lotilaner formulations 14 Dec, 2038
(14 years from now)
Active
US11690827 Methods for treating ocular Demodex using lotilaner formulations 14 Dec, 2038
(14 years from now)
Active
US11752137 Ophthalmic compositions for treating ocular Demodex using lotilaner formulations 14 Dec, 2038
(14 years from now)
Active
US8383659 Isoxazoline derivatives as pesticides 17 Jan, 2030
(5 years from now)
Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Xdemvy's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List